Cargando…
Towards reproducible computational drug discovery
The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an i...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988305/ https://www.ncbi.nlm.nih.gov/pubmed/33430992 http://dx.doi.org/10.1186/s13321-020-0408-x |
_version_ | 1783492241236426752 |
---|---|
author | Schaduangrat, Nalini Lampa, Samuel Simeon, Saw Gleeson, Matthew Paul Spjuth, Ola Nantasenamat, Chanin |
author_facet | Schaduangrat, Nalini Lampa, Samuel Simeon, Saw Gleeson, Matthew Paul Spjuth, Ola Nantasenamat, Chanin |
author_sort | Schaduangrat, Nalini |
collection | PubMed |
description | The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an in-depth coverage on the reproducibility of computational drug discovery. This review explores the following topics: (1) the current state-of-the-art on reproducible research, (2) research documentation (e.g. electronic laboratory notebook, Jupyter notebook, etc.), (3) science of reproducible research (i.e. comparison and contrast with related concepts as replicability, reusability and reliability), (4) model development in computational drug discovery, (5) computational issues on model development and deployment, (6) use case scenarios for streamlining the computational drug discovery protocol. In computational disciplines, it has become common practice to share data and programming codes used for numerical calculations as to not only facilitate reproducibility, but also to foster collaborations (i.e. to drive the project further by introducing new ideas, growing the data, augmenting the code, etc.). It is therefore inevitable that the field of computational drug design would adopt an open approach towards the collection, curation and sharing of data/code. |
format | Online Article Text |
id | pubmed-6988305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-69883052020-02-03 Towards reproducible computational drug discovery Schaduangrat, Nalini Lampa, Samuel Simeon, Saw Gleeson, Matthew Paul Spjuth, Ola Nantasenamat, Chanin J Cheminform Review The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an in-depth coverage on the reproducibility of computational drug discovery. This review explores the following topics: (1) the current state-of-the-art on reproducible research, (2) research documentation (e.g. electronic laboratory notebook, Jupyter notebook, etc.), (3) science of reproducible research (i.e. comparison and contrast with related concepts as replicability, reusability and reliability), (4) model development in computational drug discovery, (5) computational issues on model development and deployment, (6) use case scenarios for streamlining the computational drug discovery protocol. In computational disciplines, it has become common practice to share data and programming codes used for numerical calculations as to not only facilitate reproducibility, but also to foster collaborations (i.e. to drive the project further by introducing new ideas, growing the data, augmenting the code, etc.). It is therefore inevitable that the field of computational drug design would adopt an open approach towards the collection, curation and sharing of data/code. Springer International Publishing 2020-01-28 /pmc/articles/PMC6988305/ /pubmed/33430992 http://dx.doi.org/10.1186/s13321-020-0408-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Schaduangrat, Nalini Lampa, Samuel Simeon, Saw Gleeson, Matthew Paul Spjuth, Ola Nantasenamat, Chanin Towards reproducible computational drug discovery |
title | Towards reproducible computational drug discovery |
title_full | Towards reproducible computational drug discovery |
title_fullStr | Towards reproducible computational drug discovery |
title_full_unstemmed | Towards reproducible computational drug discovery |
title_short | Towards reproducible computational drug discovery |
title_sort | towards reproducible computational drug discovery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988305/ https://www.ncbi.nlm.nih.gov/pubmed/33430992 http://dx.doi.org/10.1186/s13321-020-0408-x |
work_keys_str_mv | AT schaduangratnalini towardsreproduciblecomputationaldrugdiscovery AT lampasamuel towardsreproduciblecomputationaldrugdiscovery AT simeonsaw towardsreproduciblecomputationaldrugdiscovery AT gleesonmatthewpaul towardsreproduciblecomputationaldrugdiscovery AT spjuthola towardsreproduciblecomputationaldrugdiscovery AT nantasenamatchanin towardsreproduciblecomputationaldrugdiscovery |